Biotech

Zymeworks ticks all the boxes for a biopharma investment, Paradigm says

Zymeworks (Zymeworks Stock Quote, Chart, News NYSE:ZYME) has what investors should be looking for in a biopharmaceutical company, according to Paradigm Capital analyst Corey Hammill, namely, a strong balance sheet and a healthy-looking pipeline. The analyst reviewed Zymeworks latest quarterly resul ...

Q4 2019 Share Price Performance

Q4 2019 Share Price Performance Healthcare Stocks Surge  In this blog post, the Bloom Burton equity research team summarizes the performance of the Canadian healthcare sector during 4Q-2019, and provides commentary on select stock movements and overall market trends.  Inclusion Criteria  Our ana ...

IMV gets price target cut from Raymond James

New clinical results from biopharm company IMV (IMV Stock Quote, Chart, News TSX:IMV) signal a less straightforward path to commercialization than previously assumed, according to Raymond James analyst David Novak, who reviewed the results in an update to clients on Wednesday. Dartmouth, Nova Scoti ...

Yikes to the Year End!

Originally published in December 2019 Clearly, there is more going on these days in Washington, D.C. than just the impeachment hearings, and activities this week made that point clear. In the span of only a few days, we saw progress on two key issues – the China 301 tariffs and the U.S.-Mexico-Ca ...

China – U.S. Phase 1 Deal – Means What?

Originally published in the Journal of Commerce in January 2020 As has been widely publicized, China and the U.S. signed the so-called Phase 1 deal on January 15, 2020. The agreement runs 90+ pages, the text of which can be found here: Phase 1 Deal.pdf.  The supporting U.S. Trade Representative (U ...

China – U.S. Phase 1 Deal: Is It Enough?

Originally published in January 2020 China and the U.S. signed the so-called Phase 1 deal on January 15, 2020. Much has been said in the general press and elsewhere about this deal. What does it really accomplish for international traders? First, there is nothing said about the tariffs imposed by e ...

Canada in Science – February 7, 2020

Welcome to your Canada in Science Review for February 7th, 2020! Science.  2020. Jan 17; 367(6475): 301-305 Lipid-gated monovalent ion fluxes regulate endocytic traffic and support immune surveillance Nat Cell Bio.  2020 Jan; 22(1): 120-134. Mapping the proximity interaction network of the R ...

Biotechnology in Countries Starting with “I” – Part 14: India

Earlier this month, I wrote here about the flowering of Israel’s innovative biotechnology sector over the past ten years following adoption of important IP reforms.  Now  I am returning to India, to consider the revolutionary mind shift on the key role of effective intellectual property (IP) ...

Bloom Burton & Co. Announces the 2020 Bloom Burton Award Gala

Bloom Burton & Co. Announces the 2020 Bloom Burton Award Gala Annual Award Recognizes the Most Significant Contributor to Canada’s Innovative Healthcare Industry Original press release here January 28, 2020 07:30 AM Eastern Standard Time TORONTO–(BUSINESS WIRE)–Bloom Burton & Co. (“Bloom Bu ...

Xenon Pharmaceuticals Announces Closing of its $60.0 Million Public Offering of Common Shares

Xenon Pharmaceuticals Announces Closing of its $60.0 Million Public Offering of Common Shares Original press release here BURNABY, British Columbia, Jan. 27, 2020 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc.(Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced the closing ...